A Massively Parallel CRISPR-Based Screening Platform for Modifiers of Neuronal Activity

Steven C Boggess1,2, Vaidehi Gandhi1,2, Ming-Chi Tsai3

  • 1Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.